Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chun-Fang Tong
Sorafenib-Related Adverse Events in Predicting the Early Radiologic Responses of Hepatocellular Carcinoma
Gastroenterology Research
Related publications
Efficacy and Adverse Events of Transcatheter Arterial Chemoembolization in Combination With Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma
Molecular and Clinical Oncology
Cancer Research
Oncology
Predicting Survival in Early Hepatocellular Carcinoma
Gut
Gastroenterology
Sorafenib in Hepatocellular Carcinoma
Clinical Medicine. Therapeutics
mRECIST Response Combined With Sorafenib-Related Adverse Events Is Superior to Either Criterion Alone in Predicting Survival in HCC Patients Treated With TACE Plus Sorafenib
International Journal of Cancer
Cancer Research
Oncology
Letter: Are Sorafenib-Related Adverse Events Associated With Prolonged Survival? Authors' Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Cytotoxicity of Sorafenib in Human Hepatocellular Carcinoma Cells
Al-Azhar Journal of Pharmaceutical Sciences
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Factors Predicting Early Recurrence After Surgical Resection of Hepatocellular Carcinoma
Journal of Hepatology
Hepatology
Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma
Journal of Liver Research, Disorders & Therapy
